Poland· PL-100046743
Neomycinum TZF
A neomycin product containing neomycinum, registered in Poland by Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Neomycin is registered in 6 of 19 countries.
Countries holding a registration under ATC D06AX04 (neomycin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Neomycin · ATC D06AX04
6 / 19 countries
- Finlandprice
- Germany
- Ireland
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Neomycinum
- Manufacturer
- Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- Country
- Poland (PL)
- ATC code
- D06AX04
- ATC class
- Neomycin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990085224
- gtin05909990085217
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for neomycin.
Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Neomycin · interactions on record
19 records
- 19 moderate
Most severe, free to view
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- StreptomycinJ01GA01moderate
- TobramycinJ01GB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Neomycin in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMinims neomycin 0.5% eye drops 0.5ml unit doseBausch & Lomb UK Ltd
- CanadaNEOMED 325BIO AGRI MIX LP
- NorwayNeomycin amdipharmAmdipharm
- SpainNEOMICINA SALVAT 500 MG COMPRIMIDOSLaboratorios Salvat S.A.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Portugal · Neomicina Labesfal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2c4043f0-1ddf-4fa2-992f-b62878549061 GET /v1/drugs/2c4043f0-1ddf-4fa2-992f-b62878549061?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol na skórę, zawiesina",
"source": "urpl",
"strength": "11,72 mg/g",
"packaging": "05909990085217 ¦ Rp ¦ 6992\n1 poj. 16 g\n05909990085224 ¦ Rp ¦ 6994\n1 poj. 32 g",
"substance": "Neomycini sulfas 11.72 mg/g",
"common_name": "Neomycinum",
"pl_product_id": "100046743",
"pozwolenie_nr": "00852",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about neomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.